7-methyljuglone has been researched along with diospyrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binneman, B; Fourie, PB; Hamilton, CJ; Houghton, P; Lall, N; Mahapatra, A; Mativandlela, SP; Meyer, JJ; van der Kooy, F | 1 |
| Chung, TT; Collin, F; Greive, SJ; Karkare, S; Lall, N; Maxwell, A; McKay, AR; Meyer, JJ; Mitchenall, LA | 1 |
| Chaudhari, K; Jain, P; Patel, HM; Surana, S | 1 |
| Lacey, E; Piggott, MJ; Pullella, GA; Vuong, D | 1 |
1 review(s) available for 7-methyljuglone and diospyrin
| Article | Year |
|---|---|
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
Topics: Antitubercular Agents; Clinical Trials as Topic; DNA Gyrase; Drug Discovery; Humans; Mycobacterium tuberculosis; Topoisomerase II Inhibitors | 2016 |
3 other study(ies) available for 7-methyljuglone and diospyrin
| Article | Year |
|---|---|
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Ebenaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; NADH, NADPH Oxidoreductases; Naphthoquinones; Plant Roots | 2007 |
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Binding Sites; Catalytic Domain; DNA; DNA Gyrase; Escherichia coli; Humans; Inhibitory Concentration 50; Mass Spectrometry; Models, Chemical; Mycobacterium tuberculosis; Naphthoquinones; Protein Binding; Protein Structure, Tertiary; Staphylococcus aureus; Surface Plasmon Resonance; Tuberculosis | 2013 |
Total Synthesis of the Antitumor-Antitubercular 2,6'-Bijuglone Natural Product Diospyrin and Its 3,6'-Isomer.
Topics: Antineoplastic Agents; Antitubercular Agents; Isomerism; Naphthoquinones | 2020 |